Ultralase is one of the most successful elective ophthalmic treatment (laser vision correction) providers in the world.

Its first treatment was conducted in 1991, making it the first commercial provider of laser eye treatment in the UK.

The company has 17 clinics across the UK, offering a wide range of treatments for eye conditions such as myopia, hyperopia, astigmatism and presbyopia.

This extensive range of eye treatment solutions is aimed at transforming the lives of glasses and contact lens wearers and would generally be appropriate for around 90% of the relevant population.

Ultralase operates in a fast growing sector; the refractive treatment market in the UK is expected to grow at 12% pa, with penetration rates forecast to increase significantly in the next five years, bringing the UK’s take-up level into line with more mature markets such as the US, Canada and Spain.

Ultralase aims to improve the utilisation rates of the existing network of clinics by developing strategic alliances with opticians and applying a more focused marketing strategy.

The company will continue its expansion across the UK, with four new clinic openings planned in 2008. In addition, Ultralase has entered the Irish market through the acquisition of clinics in Belfast and Waterford.